Ottawa, October 23, 2020—Innovative Medicines Canada (IMC) issued the following statement in response to the potential disclosure of proprietary or confidential business information regarding the procurement of COVID-19 medicines and […]
STATEMENT Ottawa, October 23, 2020 – Innovative Medicines Canada (IMC) issued the following statement today in response to the release of PMPRB’s final Guidelines: “For the last five years we have […]
STATEMENT Ottawa, September 25, 2020 – The following statement can be attributed to Declan Hamill, Vice President, Legal, Regulatory Affairs & Compliance, Innovative Medicines Canada in response to the Trump […]
STATEMENT Ottawa, September 23, 2020 – Pamela Fralick, President of Innovative Medicines Canada, issued the following statement in response to today’s Speech from the Throne: “COVID-19 has shown just how […]
Our members have never shied away from doing whatever it takes — because it is worth it to provide hope to people when they need it most.